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Cardiolipin, a phospholipid component of the inner mitochondrial membrane, is required for mitochondrial
metabolism. In this issue, Zhang et al. (2011) highlight a critical role for PTPMT1, a mitochondrial phospha-
tase, in cardiolipin biogenesis and possibly in cardiolipin deficiency diseases. Their findings also unveil a yet
uncharacterized pathway affecting cell growth.Alterations in the content and/or structure
of cardiolipin (CL) have been associated
with mitochondrial dysfunction in multiple
tissues and in a variety of pathological
settings, including ischemia, aging, and
heart failure (Chicco and Sparagna,
2007). Although its biosynthesis pathway
is well known, the step required for gener-
ating mitochondrial phosphatidylglycerol
(PG) (a CL intermediate) from phosphati-
dylglycerol phosphate (PGP) has simply
been described as a ‘‘dephosphorylation’’
event. Several years ago, Jack Dixon and
colleagues, using a screen based on
sequence similarity of the catalytic site
domain of PTEN, discovered a new
member of the PTP family named
PTPMT1 (for PTP localized to mitochon-
drion 1) (Pagliarini et al., 2004). PTPMT1
was the first phosphatase found in mito-
chondria, where it resides exclusively on
the inner membrane facing the mitochon-
drial matrix (Pagliarini et al., 2005; Boi-
sclair and Tremblay, 2005). In this issue,
Zhang et al. (2011) demonstrate that
PTPMT1 dephosphorylates PGP and
that this dephosphorylation is necessary
for mitochondrial function through its
regulation of CL biosynthesis. Moreover,
since gene targeting of PTPMT1 leads to
decreased cell growth even before the
appearance of cardiolipin depletion, it
suggests that PTPMT1 plays an additional
and undefined role in cell metabolism.
This study therefore expands our under-
standing of CL biosynthesis pathway
and sheds light on a potentially new func-
tion of PTPMT1 in mitochondria.
As a first step in characterizing the
in vivo function of PTPMT1, Zhang et al.
(2011) began characterizing the PTPMT1
knockout mouse. These mice demon-
strated embryonic lethality before dayE8.5, suggesting that PTPMT1 plays an
indispensable role during development.
To understand the biological function
of PTPMT1, the authors infected
Ptpmt1flox/flox mouse embryonic fibro-
blasts (MEFs) with adenovirus to mediate
Cre deletion. Ptpmt1-null cells displayed
inhibition of proliferation and growth,
but were not apoptotic or necrotic and
had cell sizes similar to Ptpmt1-flox
MEFs. These controls were important,
because decreased CL levels or oxida-
tive states have been shown to lead to
apoptosis (Kagan et al., 2005).
The position of PTPMT1 on the inner
mitochondrial membrane places it within
close proximity to machinery responsible
for ATP synthesis and electron transport
chain complexes. This led Dixon’s group
to examine the role of this phosphatase
on mitochondrial respiration and oxida-
tive phosphorylation (ATP production)
using Ptpmt1-flox and Ptpmt1-null
MEFs. They found that PTPMT1 depletion
inhibits mitochondrial respiration but
increases cellular ATP content and that
this occurs before any major depletion of
CL. This increase was more pronounced
after preincubation of cells with low
glucose, suggesting that elevation of
ATP levels in knockout cells may result
from increased glycolysis. This hypoth-
esis is supported by increased lactate
production observed in Ptpmt1-null cells.
This reduced usage of energy may also
contribute to increased cellular ATP
content. Although the exact mechanism
by which the reduction or deletion of
PTPMT1 increased ATP levels is not yet
known, it will be an important focus of
future studies (Pagliarini et al., 2005;
Zhang et al., 2011). Interestingly, AMP-
activated protein kinase (AMPK) playsCell Metabolisma role in controlling energy homeostasis
by modulating cellular ATP levels, and its
activity is increased in low glucose situa-
tion (Zhang et al., 2009). This could poten-
tially be a signal to compensate the
decrease in CL levels by promoting ATP
production via glycolysis. Consistent
with this putative role of AMPK in this
model, a decrease in mitochondrial CL
content and function has been also
observed in AMPKa2-deficient mice
(Athe´a et al., 2007).
Consistent with the decrease in respira-
tory rates of Ptpmt1-null cells, the authors
found a profound inhibition of complex
I and II activity in isolated mitochondria
of cells lacking PTPMT1. Because mito-
chondrial CL contributes to the assembly
of these complexes in yeast (Zhang
et al., 2005), these results suggest that
PTPMT1’s role in mitochondrial respira-
tion is likely via its regulation of CL. More-
over, it suggests that the decrease of this
mitochondrial phospholipid could also
affect the integrity of the mitochondria.
Interestingly, the authors observed
a variety of morphological abnormalities
in Ptpmt1-null cells, including rupture of
outer mitochondrial membranes and frag-
mentation of cristae and matrix compo-
nents (Figure 1). Consequently, reduced
expressionof thisenzymeresults inamito-
chondrial bioenergetics defect, leading to
a metabolic switch in these cells. This
could also explain the change in ATP
levels and glycolytic flux observed in
Ptpmt1-null MEFs.
The phospholipids cytidinediphos-
phate-diacylglycerol (CDP-DAG), PG,
and PGP are important intermediates for
the synthesis of cardiolipin in the inner
membrane of mitochondria (Osman et al.,
2011). In eukaryotes, CL is synthesized13, June 8, 2011 ª2011 Elsevier Inc. 615
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Figure 1. Schematic Model for the Regulation of Cardiolipin Biosynthesis Pathway by PTPMT1
(A) Cardiolipin (CL) synthesis begins with the acylation of glycerol-3-phosphate (G3P) by G3P acyltransferase to form phosphatidic acid, which is then converted
to cytidinediphosphate-diacylglycerol (CDP-DAG) by the enzyme CDP-DAG synthase. Further steps in CL biosynthesis take place in the inner membrane of
mitochondria. These steps involve the conversion of CDP-DAG to phosphatidylglycerol (PG) by the stepwise action of PG phosphate (PGP) synthase and the
recently identified PTPMT1 phosphatase (Zhang et al., 2011). CL is subsequently generated from PG and CDP-DAG by CL cardiolipin synthase.
(B) PTPMT1 phosphatase plays a crucial role in maintaining optimal mitochondrial function through its regulation of cardiolipin biosynthesis. The loss of this phos-
phatase leads to mitochondrial dysfunction due to dramatic reduction in cardiolipin levels, resulting in defective respiration, abnormal morphology, and delay of
cell growth.
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synthase, PGP phosphatase, and CL
synthase. The PGP phosphatase involved
in this pathway, however, was not known.
In their effort to identify the endogenous
substrate(s) of this phosphatase via
a lipidomics approach, Zhang et al.
(2011) observed an accumulation of PGP
with a concomitant decrease in PG in
Ptpmt1-null MEFs compared to Ptpmt1-
flox cells. This finding, supported by
a phosphatase activity assay, beautifully
identifies PTPMT1 as the phosphatase
responsible for the conversion of PGP to
PG. As this conversion constitutes an
integral part of the CL biosynthetic
pathway, the authors expanded their
analysis to examine whether the loss of
PTPMT1 alters CL content in cells. As
expected, mass spectrometry analysis
of phospholipids revealed a marked
decrease in CL content in Ptpmt1-null
MEFs versus Ptpmt1-flox MEFs, indi-616 Cell Metabolism 13, June 8, 2011 ª2011cating that PTPMT1 is necessary for CL
biosynthesis and suggesting that the
profound defects inmitochondrial respira-
tory capacity and membrane integrity
observed in Ptpmt1-null cells is due to
CL deficiency (Figure 1).
The elegant studies presented in this
paper complete the understanding of
the CL synthesis pathway, identifying
PTPMT1 as the phosphatase responsible
for converting PGP to PG and revealing its
role as an important regulator of mito-
chondrial morphology and metabolism
through its regulation of CL biosynthesis.
Many questions arise from this important
work. Since CL and PG levels remained
detectable in Ptpmt1-null cells, is
PTPMT1 perhaps not the only phospha-
tase responsible for the conversion of
PGP to PG, or, alternatively, do other
metabolic pathways lead to PG produc-
tion? What is the CL independent mecha-
nism affecting cell growth and ATPElsevier Inc.production? Importantly, as this question
is raised by the authors, do any human
diseases with CL deficiency involvemuta-
tions in PTPMT1? Clearly, the results of
the present study have not only opened
the door to exciting new research direc-
tions in mitochondrial function, but they
have also generated a small but signifi-
cant change in all future biochemistry
textbooks.REFERENCES
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TOR (target of rapamycin) signaling regulates life span in many organisms, but the mechanism behind the
effect is unknown. In this issue of Cell Metabolism, Pan and colleagues (2011) find that reduced TORC1
activity promotes yeast life span via a mechanism that, paradoxically, relies upon the production of normally
deleterious reactive oxygen species.The budding yeast Saccharomyces
cerevisiae has proven to be a remarkably
fruitful model for aging researchers.
S. cerevisiae undergoes two distinct types
of aging: replicative aging, in which the
number of daughter cells that bud from
a single mother cell is tallied, and chrono-
logical aging, which is defined by the
length of time that a yeast culture can
maintain viability in stationaryphase.Yeast
replicative aging is mediated, at least in
part, by translation, and longevity can
be promoted by deletion of ribosomal
subunits (reviewed in Kaeberlein and
Kennedy, 2011). Yeast chronological life
span, however, is thought to be heavily
dependent on resistance to oxidative
stress (Fabrizio et al., 2003).
Inhibition of TOR (target of rapamycin)
signaling in yeast, either by deletion of
TOR1 or by treatment with rapamycin,
an FDA-approved inhibitor of mTOR sig-
naling, extends both chronological and
replicative life span (Ha and Huh, 2011;
Medvedik et al., 2007; also reviewed in
Kaeberlein and Kennedy, 2011). Studies
in yeast, C. elegans, and D. melanogaster
have linked TOR-mediated life span
extension to inhibition of translation andsuggest that calorie restriction (CR), an
intervention that extends the life span
of many organisms, including mammals,
works to some extent through similar
mechanisms (reviewed in Kaeberlein and
Kennedy, 2011). Recent work demon-
strating that rapamycin can extend the
life span of mice has generated significant
interest in understanding the mechanism
by which inhibition of mTOR signaling
promotes life span extension (Harrison
et al., 2009).
Recently, the validity of using yeast
chronological life span as a longevity
model has been questioned, with the
discovery that yeast chronological life
span is significantly inhibited by the
buildup of acetic acid and ethanol in the
growth media (Burtner et al., 2009; Fabri-
zio et al., 2005). In this issue ofCell Metab-
olism, Pan and colleagues (2011) show
that the effect of TOR on life span in yeast
is cell-intrinsic and demonstrate that re-
duced TORC1 signaling leads to in-
creased mitochondrial respiration during
logarithmic phase growth, with increased
generation of reactive oxygen species
(ROS) (Figure 1). Blocking this increase
in ROS by overexpressing SOD2, theyeast mitochondrial superoxide dismu-
tase, significantly decreases the ability
of TOR inhibition to extend life span.
This shows that the superoxide signal is
the key to yeast chronological life span
extension.
Pan and colleagues’ work supports the
validity of yeast chronological life span as
a model for aging, and not simply as an
assay for resistance to the detrimental
effects of acetic acid, as previously sug-
gested (Burtner et al., 2009). The authors
find that neutralizing the media, which
was previously shown to extend yeast
chronological life span, significantly alters
mitochondrial metabolism. In a series of
elegant media-exchange experiments,
the authors demonstrate that the effect
of TOR on chronological life span is not
affected by a differential accumulation of
acetic acid or other metabolites in the
growth media of tor1D yeast. While yeast
replicative aging genesmore closely over-
lap genes that extend life span in
C. elegans than yeast chronological life
span genes (Burtner et al., 2011), homo-
logs of yeast chronological life span genes
may still play a role in life span in higher
organisms, and it seems likely that yeast13, June 8, 2011 ª2011 Elsevier Inc. 617
